VolitionRx (VNRX) announced the pricing of an underwritten public offering of 11.55M shares of its common stock and warrants to purchase up to 11.55M shares of its common stock. The public offering price of for each share of common stock and an accompanying warrant to purchase one share of common stock is 52c per set of securities. Each warrant has an exercise price per share of 60c, is exercisable immediately upon issuance, and expires five years from the issuance date. All of the securities in the offering are being offered by Volition. The offering is expected to close on or about October 14, subject to the satisfaction of customary closing conditions. Newbridge Securities is acting as the sole book-running manager of the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VNRX:
- VolitionRx announces offering of common stock and warrants, no amount given
- Strategic Partnerships and Growth Potential Justify Buy Rating for VolitionRX
- VolitionRx signs co-marketing and services agreement with Hologic
- VolitionRX’s Strategic Partnership and Growth Potential Drive Buy Rating
- VolitionRx signs first human out licensing deal for APS